Midlands State University Library
Image from Google Jackets

Clinical cardio-oncology / created by Joerg Herrmann, MD, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.

By: Contributor(s): Material type: TextTextPublisher: Elsevier, 2017Description: xxi, 491 pages : illustrations (some coloured) ; 26 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9780323442275
  • 0323442277
Subject(s): LOC classification:
  • RC681 HER
Contents:
Title page; Table of Contents; Copyright; Contributors; Preface; Introduction; Section 1: Oncology and Hematology Principles for the Cardiologist; Chapter 1. Principles of Cancer Treatment; Cancer presentation; Cancer staging; Cancer treatment; Radiation therapy; Supportive care for the patient with cancer; Myelotoxicity; Hypersensitivity reactions; Chapter 2. Introduction to Systemic Antineoplastic Treatments for Cardiologists; Introduction; Practical approaches to systemic anticancer treatments; Targeted cancer therapies; Antibody drug conjugates; Immune checkpoint therapies. The future of systemic anticancer treatmentChapter 3. Basics of Radiation Therapy; Introduction; Basic physics; Types of radiation; Sources of radiation; Radiation interactions in the body; Radiation treatment planning and delivery; Radiation treatment parameters; Relative biological effectiveness; Practical aspects of radiation therapy planning and delivery; Specific modalities; Specific disease sites; Summary; Chapter 4. Cardiac Tumors: Overview and Pathology; Overview; Nonneoplastic tumors; Pediatric and congenital tumors; Lesions of uncertain cause; Benign primary cardiac neoplasms. Malignant primary cardiac neoplasmsMetastatic cardiac neoplasms; Secondary effects of neoplasms on the heart; Chapter 5. Cardiac Tumors: Imaging; Introduction; Imaging modalities; Pseudotumors; Benign; Primary cardiac malignancies; Metastatic malignancies; Case study 1; Case study 2; Case study 3; Chapter 6. Cardiac Tumors: Treatment; Nonneoplastic tumors; Benign primary cardiac neoplasms; Primary malignant tumors; Secondary metastatic tumors; Right atrial extension of subdiaphragmatic tumors; Molecular- and biologic-based diagnosis and therapy for cardiac tumors; Important points; Case study. Supplementary dataChapter 7. Subtypes of Cancer Involving the Heart; Carcinoid; Cardiac amyloid; Pheochromocytoma; Diagnosis; Section 2: Cardiac Complications from Cancer Therapy; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Introduction; Cardiomyopathies; Anthracyclines; Human epidermal growth factor receptor-2/epidermal growth factor receptor-2 targeted therapies; Anthracyclines and human epidermal growth factor receptor-2/epidermal growth factor receptor-2 targeted therapies; Approach to heart failure in the patients with cancer; Summary. Chapter 9. Vascular Toxicities of Cancer TherapiesPart 1: chemotherapeutics associated with vascular toxicity; Part 2: clinical presentations of chemotherapy-related vascular toxicities; Case study; History; Current medications; Current symptoms; Physical examination; Laboratory data; Electrocardiogram (if applicable. Please provide figure and brief description); Focused clinical questions and discussion points (provide 3 to 5 questions and discussions); Final diagnosis; Plan of action; Intervention; Outcome; Selected reference
Reviews from LibraryThing.com:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Book Book Main Library Open Shelf RC681 HER (Browse shelf(Opens below)) 162122 Available BK150077

Includes bibliographical references and index.

Title page; Table of Contents; Copyright; Contributors; Preface; Introduction; Section 1: Oncology and Hematology Principles for the Cardiologist; Chapter 1. Principles of Cancer Treatment; Cancer presentation; Cancer staging; Cancer treatment; Radiation therapy; Supportive care for the patient with cancer; Myelotoxicity; Hypersensitivity reactions; Chapter 2. Introduction to Systemic Antineoplastic Treatments for Cardiologists; Introduction; Practical approaches to systemic anticancer treatments; Targeted cancer therapies; Antibody drug conjugates; Immune checkpoint therapies. The future of systemic anticancer treatmentChapter 3. Basics of Radiation Therapy; Introduction; Basic physics; Types of radiation; Sources of radiation; Radiation interactions in the body; Radiation treatment planning and delivery; Radiation treatment parameters; Relative biological effectiveness; Practical aspects of radiation therapy planning and delivery; Specific modalities; Specific disease sites; Summary; Chapter 4. Cardiac Tumors: Overview and Pathology; Overview; Nonneoplastic tumors; Pediatric and congenital tumors; Lesions of uncertain cause; Benign primary cardiac neoplasms. Malignant primary cardiac neoplasmsMetastatic cardiac neoplasms; Secondary effects of neoplasms on the heart; Chapter 5. Cardiac Tumors: Imaging; Introduction; Imaging modalities; Pseudotumors; Benign; Primary cardiac malignancies; Metastatic malignancies; Case study 1; Case study 2; Case study 3; Chapter 6. Cardiac Tumors: Treatment; Nonneoplastic tumors; Benign primary cardiac neoplasms; Primary malignant tumors; Secondary metastatic tumors; Right atrial extension of subdiaphragmatic tumors; Molecular- and biologic-based diagnosis and therapy for cardiac tumors; Important points; Case study. Supplementary dataChapter 7. Subtypes of Cancer Involving the Heart; Carcinoid; Cardiac amyloid; Pheochromocytoma; Diagnosis; Section 2: Cardiac Complications from Cancer Therapy; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Introduction; Cardiomyopathies; Anthracyclines; Human epidermal growth factor receptor-2/epidermal growth factor receptor-2 targeted therapies; Anthracyclines and human epidermal growth factor receptor-2/epidermal growth factor receptor-2 targeted therapies; Approach to heart failure in the patients with cancer; Summary. Chapter 9. Vascular Toxicities of Cancer TherapiesPart 1: chemotherapeutics associated with vascular toxicity; Part 2: clinical presentations of chemotherapy-related vascular toxicities; Case study; History; Current medications; Current symptoms; Physical examination; Laboratory data; Electrocardiogram (if applicable. Please provide figure and brief description); Focused clinical questions and discussion points (provide 3 to 5 questions and discussions); Final diagnosis; Plan of action; Intervention; Outcome; Selected reference

There are no comments on this title.

to post a comment.